Impact on patient of the detection of weakly expressed RhD antigens in blood donors

about

Transfusion Medicine and Molecular Genetic Methods.

P2860

Q55234148-62F8E1BD-B503-4D52-B682-5088F7D980C8

P2860

Impact on patient of the detection of weakly expressed RhD antigens in blood donors

Item

http://www.wikidata.org/entity/Q36387410

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Impact on patient of the detection of weakly expressed RhD antigens in blood donors

@ast

Impact on patient of the detection of weakly expressed RhD antigens in blood donors

@en

type

Item

label

Impact on patient of the detection of weakly expressed RhD antigens in blood donors

@ast

Impact on patient of the detection of weakly expressed RhD antigens in blood donors

@en

prefLabel

Impact on patient of the detection of weakly expressed RhD antigens in blood donors

@ast

Impact on patient of the detection of weakly expressed RhD antigens in blood donors

@en

P1476

Impact on patient of the detection of weakly expressed RhD antigens in blood donors

@en

P2093

Vitor Mendonça Alves

http://www.w3.org/2001/XMLSchema#string

P2860

RHD variants in Polish blood donors routinely typed as D-

Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria.

It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Impact of a confirmatory RhD test on the correct serologic typing of blood donors.

The genetics of the Rhesus blood group system.

RHD variants in Flanders, Belgium.

Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India.

RHD alleles and D antigen density among serologically D- C+ Brazilian blood donors.

Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA.

[The molecular basis of RH system and its applications in obstetrics and transfusion medicine].

P304

290-291

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BJHH.2015.07.007

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

H Moraes-Souza

P577

2015-08-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282243950

http://www.w3.org/2001/XMLSchema#string

P698

26408360

http://www.w3.org/2001/XMLSchema#string

P932

4685078

http://www.w3.org/2001/XMLSchema#string

Impact on patient of the detection of weakly expressed RhD antigens in blood donors

about

P2860

P2860

Impact on patient of the detection of weakly expressed RhD antigens in blood donors

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932